- Inicio
- Análisis de app
- Almee
- Almee Vs. CSL Behring CSL222_3005
Almee vs CSL Behring CSL222_3005 Uso & Estadísticas
INVESTIGATIONAL DEVICE - Only available for participants in the ongoing clinical investigation. Check if you are able to enroll here: www.vicorecompanionstudy.com
Almee (an investigational medical device pending FDA clearance) is a digital therapeutic intended to provide cognitive behavioral therapy (CBT) to address symptoms of anxiety and to improve the quality of life in patients aged 22 and older with pulmonary fibrosis (PF).
How Almee works
The treatment takes nine weeks to complete and consists of seven Therapy modules and three Essentials modules. In the therapy program, you’ll learn about various topics such as motivation, feelings and behaviors, values and living in line with your personal values, mindfulness, dealing with troubling thoughts, and much more. The Essentials modules contain tools and information about physical activity, better sleep and nutrition, and how to manage PF symtoms. You’ll go through the Therapy modules sequentially, one by one, while you can work with the Essentials modules at any time.
For more information about Almee, visit almeetherapy.com
- App Store de Apple
- Gratis
- Salud y fitness
Clasificación de tiendas
- -
The CSL Behring COA App is intended for use collect patient reported outcomes relating to a clinical trial. Patients must be given accounts by a participating site in order to login to the app.
- App Store de Apple
- Gratis
- Medicina
Clasificación de tiendas
- -
Almee frente a CSL Behring CSL222_3005: comparación de la clasificación
Comparar la tendencia de clasificación de Almee en los últimos 28 días con CSL Behring CSL222_3005
Rank
No hay datos disponibles
Comparación de las clasificaciones Almee frente a CSL Behring CSL222_3005 por países
Comparar la tendencia de clasificación de Almee en los últimos 28 días con CSL Behring CSL222_3005
No hay datos para mostrar
Compara con cualquier sitio gracias a nuestra prueba gratuita
Almee VS.
CSL Behring CSL222_3005
enero 1, 2025